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ABSTRACT 
Diversity at pathogen genetic loci can be 
driven by host adaptive immune selection 
pressure and may reveal proteins important 
for parasite biology. Population-based 
genome sequencing of Plasmodium 
falciparum - the parasite responsible for the 
most severe form of malaria - has highlighted 
two related polymorphic genes called dblmsp 
and dblmsp2, which encode Duffy binding-
like (DBL) domain-containing proteins 
located on the merozoite surface but whose 
function remains unknown. Using 
recombinant proteins and transgenic 
parasites, we show DBLMSP and DBLMSP2 
directly and avidly bind human 
immunoglobulin M (IgM) via their DBL 
domains. We used whole genome sequence 
data from over 400 African and Asian P. 
falciparum isolates to show that dblmsp and 
dblmsp2 exhibit extreme protein 
polymorphism in their DBL domain, with 
multiple variants of two major allelic classes 
present in every population tested. Despite 
this variability, the IgM-binding function was 
retained across diverse sequence 
representatives. While this interaction did not 
seem to have an effect on the ability of the 
parasite to invade red blood cells, binding of 
DBLMSP and DBLMSP2 to IgM inhibited 
the overall immunoreactivity of these 
proteins to IgG from patients who had been 
exposed to the parasite. This suggests that 
IgM binding might mask these proteins from 
the host humoral immune system. 
 
 
Malaria is responsible for up to one million 
deaths annually and therefore remains one of 
the world’s major health problems (1,2). 
Amongst the different species of Plasmodium 
causing malaria in humans, Plasmodium 
falciparum is responsible for the highest 
burden of disease. The clinical symptoms of 
malaria are associated with the blood stage of 
the infection, when the merozoite stage of the 
parasite recognises, invades and develops 
within human erythrocytes (3). Because 
merozoites are directly exposed to circulating 
antibodies, and passive immunisation of 
infected children with purified 
immunoglobulins from clinically-immune 
individuals reduces parasitaemia (4), 
merozoite surface proteins are considered 
likely targets of host immunity and therefore 
potential vaccine candidates (5). Consistent 
with this, population-based P. falciparum 
genome sequence analysis (6) has revealed 
that genes encoding merozoite surface 
proteins are amongst the most polymorphic 
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in the genome, with several exhibiting 
signatures of balancing selection, suggesting 
that host immune pressure maintains the 
presence of multiple distinct antigenic 
variants (7).  
dblmsp and dblmsp2 (also known as msp3.4 
and msp3.8, respectively) are two members 
of the P. falciparum msp3 family which 
comprises a cluster of eight paralogous genes 
on chromosome 10. The msp3 family 
encodes proteins characterised by the 
presence of an NLR[K/N][A/G/N] motif at 
their N-terminus (8,9), are secreted by the 
blood stage of the parasite, and located in 
both the parasitophorous vacuole and on the 
merozoite’s surface. Most proteins within 
this family also contain a C-terminal acidic 
and a coiled-coil region believed to be 
involved in oligomerisation of the proteins 
(10), which form the SPAM (secreted 
polymorphic antigen associated with 
merozoites) domain (11). DBLMSP and 
DBLMSP2 are distinguished from the other 
MSP3-family members because they contain 
a Duffy binding-like (DBL) domain (8,12). 
DBL domains are known to bind directly to 
host receptors and are present in other P. 
falciparum surface proteins including ligands 
involved in erythrocyte invasion such as 
EBA175 and EBA140 (13-15) and members 
of the PfEMP1 family, which are displayed 
on the surface of the infected erythrocyte 
(16). Sequencing of some African P. 
falciparum strains has shown that the genetic 
diversity in dblmsp and dblmsp2 is 
particularly high and concentrated in the 
region encoding the DBL domain (17-19). 
Clearly identifiable orthologues of dblmsp 
and dblmsp2 are not present in other 
Plasmodium species that infect humans, but 
the genome of the chimpanzee parasite P. 
reichenowi encodes a functional dblmsp 
gene, although dblmsp2 is a pseudogene (19). 
Despite these interesting features, the 
function of DBLMSP and DBLMSP2 and 
their role in the pathology of malaria are 
unknown. 
Here, we used recombinant proteins 
produced in mammalian cells and a knock-
out parasite line to show that the DBL 
domains of DBLMSP and DBLMSP2 from 
the 3D7 strain of P. falciparum bind avidly 
and directly to human IgM. Using 
population–based genome sequencing and 
bespoke assembly tools, we revealed 
widespread genetic diversity focussed on the 
DBL domain, with two major allelic forms of 
both dblmsp and dblmsp2 observed in 
populations from Africa and South-East 
Asia. Despite their diversity, binding of the 
DBL domains from different DBLMSP and 
DBLMSP2 sequence variants to human IgM 
was conserved, suggesting an important role 
in the parasite’s biology. 
 
RESULTS 
DBLMSP and DBLMSP2 bind 
human IgM - To gain insight into the 
functional role of DBLMSP and DBLMSP2 
during malaria pathogenesis, we first 
expressed the entire coding region of both 
proteins from the P. falciparum 3D7 strain 
using a recently developed expression system 
based on mammalian cells, which has been 
shown to produce natively-folded P. 
falciparum proteins (20). Both proteins were 
expressed (Fig. 1A), and their 
immunoreactivity to sera from malaria-
exposed and unexposed control individuals 
was quantified. To our surprise, while other 
MSP3 family members (MSP3, MSP6, H101 
and MSP11) and DBL-containing merozoite 
surface proteins (EBA140, EBA175, 
EBA181) reacted, as expected, with only the 
exposed sera, DBLMSP and DBLMSP2 
showed equally strong immunoreactivity to 
both the unexposed control and exposed sera 
(Fig. 1B). This suggested that recombinant 
DBLMSP and DBLMSP2 bound 
immunoglobulins present in normal serum 
from individuals without prior exposure to 
the malaria parasite. Indeed, when each 
protein was exposed to purified human 
immunoglobulin isotypes, strong binding was 
observed to IgM, but not to IgA, IgE, or IgG 
(Fig. 1C). This binding was specific to 
human IgM since they did not bind 
immunoglobulins from other mammalian 
species including goat, rabbit, guinea pig and 
cow, or purified mouse IgM (Fig. 1D). To 
confirm these observations, we showed that 
DBLMSP-coated beads but not control beads 
incubated in normal human serum purified 
bands with masses there were consistent with 
the heavy and light chain of IgM (Fig. 1E), 
and their identities were subsequently 
confirmed by mass spectrometry. 
IgM adopts a flat, planar structure in 
solution but can change to a “staple” 
conformation upon antigen binding thereby 
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permitting interaction with other proteins 
such as C1q (21). To determine whether 
antigen bound to IgM influenced its 
interaction with DBLMSP and DBLMSP2, 
we made use of two transfectomas producing 
chimeric IgMs that recognise dinitrophenyl 
(DNP), but differ by either the presence or 
absence of a murine J-chain. In these 
chimeric IgMs, the whole κ light chain and 
the variable region of the heavy chain are of 
murine origin, whereas the heavy chain Fc 
constant region is human (22). DBLMSP and 
DBLMSP2 bound IgM from both 
transfectomas demonstrating that they 
interact with the human IgM heavy chain 
constant region, and this binding was 
independent of whether they were engaged 
with antigen or not. Binding of DBLMSP2 to 
IgMs lacking a J-chain, however, was 
consistently weaker (Fig. 1F). 
The DBL domain of DBLMSP and 
DBLMSP2 binds directly and avidly to the 
IgM Cμ4 domain - To identify the region on 
IgM that bound DBLMSP and DBLMSP2, 
we used mouse monoclonal antibodies that 
bind to specific domains of the human μ 
chain constant region (23,24). Antibody 1G6, 
whose epitope is located within the Cμ4 
domain, inhibited the interaction of 
DBLMSP and DBLMSP2 with human IgM 
whereas antibodies IX11 and HB57, with 
epitopes located in the Cμ1 and Cμ2 domains, 
respectively, or the Cμ3-specific antibodies 
196.6b and 5D7 did not (Fig. 2A). To 
confirm these observations, we also made use 
of chimaeric recombinant antibodies in 
which domains of the human μ chain 
constant region replace domains from the 
human α or γ chain (25,26). In all cases, 
binding of DBLMSP and DBLMSP2 proteins 
was observed only when the Cμ4 domain was 
present in the chimaeric antibodies, and no 
binding was detected with domain-swapped 
antibodies only containing the Cμ2 or Cμ3 
domains (Fig. 2B). 
To determine which regions of 
DBLMSP and DBLMSP2 were involved in 
IgM binding, we individually expressed 
either the DBL domain, or the SPAM 
fragment. The SPAM fragments did not bind 
IgM whereas the isolated DBL domains 
bound IgM as efficiently as the full-length 
proteins in this assay, indicating that the 
DBL domain encompassed all IgM binding 
activity (Fig. 2C). 
DBLMSP and DBLMSP2 form 
multimers that interact avidly with human 
IgM - To determine whether DBLMSP and 
DBLMSP2 could, like MSP3, form 
oligomers, we first used size-exclusion 
chromatography on each full-length protein. 
In both cases, polydisperse peaks were 
observed, suggesting the formation of higher 
order oligomers composed exclusively of the 
proteins of interest (Fig. 3A). We then 
resolved purified proteins encompassing the 
DBL domain and SPAM fragment by size-
exclusion chromatography. While the DBL 
domain of DBLMSP2 eluted as a single 
monodisperse peak consistent with it being a 
monomer, the SPAM fragment elution 
profile was polydisperse, with peaks 
consistent with tetrameric and other higher 
order complexes, and only a minor fraction 
consistent with a monomeric form (Fig. 3B). 
A similar analysis of DBLMSP gave 
comparable results, suggesting that both 
DBLMSP and DBLMSP2 are able to form 
higher-order oligomers by interactions 
through their C-terminus. 
To quantify the interaction between 
IgM and both DBLMSPs, and demonstrate 
that the proteins interacted directly, we used 
surface plasmon resonance. Binding of 
soluble, purified human IgM was tested 
against immobilised full-length DBLMSP or 
DBLMSP2, mimicking the orientation of the 
proteins that would be expected in vivo. IgM 
binding to both parasite proteins was clearly 
saturable, demonstrating the specificity of the 
interactions, with equilibrium binding 
constants (KDs) of 0.3 and 1.1 nM for 
DBLMSP and DBLMSP2, respectively (Fig. 
3C). Given the multimeric nature of both 
IgM and the two parasite proteins studied, 
these measurements reflect overall binding 
avidity and are not easily comparable with 
other monomeric protein interactions. We 
therefore immobilised human IgM on the 
chip and used the monomeric DBL domains 
as analytes. Using this approach, the affinity 
for human IgM was 200- to 550-fold weaker 
reflecting the loss of avidity but nonetheless 
still strong, with an equilibrium binding 
affinity of 60nM for DBLMSP versus 600nM 
for DBLMSP2 (Fig. 3D). The physiological 
concentration of IgM in human serum is 
around 1-2 mg/mL (1-2 μM), which is at 
least three orders of magnitude higher than 
the measured binding constants, and implies 
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that all serum-exposed DBLMSP and 
DBLMSP2 would be rapidly and irreversibly 
complexed with IgM. 
dblmsp-deficient merozoites invade 
erythrocytes efficiently but do not bind IgM - 
To demonstrate that native DBLMSP could 
bind human IgM, we generated Δdblmsp P. 
falciparum merozoites in which the dblmsp 
gene has been targeted (Fig. 4A), and 
confirmed this by Southern blotting (Fig. 
4B). Using an antibody raised against the 
SPAM region of DBLMSP, we showed that 
the Δdblmsp parasites no longer expressed 
DBLMSP protein (Fig. 4C) and that it was 
absent from the surface of merozoites (Fig. 
4D). We then used immunohistochemistry to 
test for the presence of human IgM at the 
surface of 3D7 wild-type, or Δdblmsp 
parasites. In wild-type parasites, DBLMSP is 
expressed at the surface of merozoites in all 
schizonts, whereas DBLMSP2 is present in 
only a very small subset of schizonts (1% or 
less; (17)). Following culture in the presence 
of purified human IgM or with human serum, 
IgM could be detected readily at the surface 
of wild-type but not dblmsp-deficient 
merozoites (Fig. 5A). These observations 
were further confirmed by immunoelectron 
microscopy of purified wild-type and knock-
out merozoites incubated in the presence of 
purified human IgM, which showed regular 
punctate labelling at the surface of wild-type 
but not Δdblmsp merozoites (Fig. 5B). These 
data demonstrate that native DBLMSP binds 
IgM and is the sole IgM-binding protein at 
the surface of most merozoites. Δdblmsp 
knock-out mutants grown in the presence of 
medium containing a serum alternative that 
does not contain human IgM did not show 
any invasion phenotype when compared to 
the wild-type. To determine whether the 
presence of human IgM on the merozoite 
surface had any effect on the ability of the 
wild-type parasite to invade red blood cells, 
we also performed invasion assays with 
parasites grown in either serum alternative 
alone, or serum alternative supplemented 
with 1 mg/mL human IgM. No difference in 
invasion efficiency was observed, suggesting 
that the presence of human IgM on the 
merozoite surface does not affect erythrocyte 
invasion in vitro (Fig. 5C). 
dblmsp and dblmsp2 are dimorphic – 
Our observations suggest that the DBLMSP 
and DBLMSP2 proteins from the 3D7 strain 
of Plasmodium falciparum parasite are able 
to bind human IgM. Sequencing of some P. 
falciparum isolates from Africa has, 
however, shown sequence variability in 
dblmsp and dblmsp2 (17-19). To further 
characterise the genetic diversity in these two 
genes, we looked at the sequence variability 
amongst field isolates from Africa and 
South-East Asia. Characterising and 
quantifying genetic architecture in field 
isolates using population-based genomic 
sequencing are challenging both because of 
their high degree of polymorphism, and the 
appreciable levels of mixed infections. To 
circumvent these issues, we applied the 
Cortex de novo variation assembler (27,28), 
which constructs a so-called de Bruijn graph 
representing the sequence and variation 
within the sample without the use of a 
reference genome. This method is agnostic to 
different types of genetic variation including 
indels and structural variants, and is highly 
specific. Using this method we generated 
biallelic variant calls across the P. falciparum 
genome using short-read Illumina sequence 
data from 434 field isolates from The 
Gambia, Ghana, Guinea, and Cambodia 
(minimum 50x coverage, mean read length 
74 bp) as reported elsewhere (17,29,30). 
Comparing genome sequences across P. 
falciparum isolates revealed striking regions 
of high sequence diversity, for example on 
chromosome 10 (Fig. 6A), and in particular 
around the MSP3 gene family. Using this 
approach, the highest peak was observed at 
msp3 whose two diverged haplotypes - 
within which recombination is reduced - 
have been very well-studied in the literature, 
and whose divergence precedes the P. 
reichenowi/P. falciparum split (31); 
however, we also observed extremely high 
peaks at dblmsp and dblmsp2. 
After close examination of the 
variant calls within dblmsp and dblmsp2, we 
found a large number of overlapping 
variants. Since Cortex only calls biallelic 
variants, samples with multiple infections, 
which contain more than two alleles at a 
single site, will return no value. Because few 
sites were multi-allelic in all samples, we 
took the union of all sites in the 434 samples 
and removed redundancy - this union 
contained the vast majority of polymorphic 
sites. The overlapping alleles in dblmsp and 
dblmsp2 were long (up to around 1kb), and 
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shared sequence. As a result of this, together 
with the unknown multiplicity of infection 
and lack of phasing information with the 
short Illumina reads, we took a conservative 
approach and did not attempt to genotype the 
implied long multi-allelic variants. Applying 
these approaches, we established that dblmsp 
and dblmsp2 each contained one major 
cluster of long non-recombining haplotypes 
(15 haplotypes in dblmsp, and 41 in 
dblmsp2), with differing lengths (around 570 
bp in dblmsp, and 1350 bp in dblmsp2) and 
all overlapping the region encoding the DBL 
domain. In dblmsp, these 15 haplotypes 
grouped into two major allelic forms which 
we termed class 1 (three haplotypes) and 2 
(12 haplotypes) (Fig. 6B and 6C). In 
dblmsp2, we found two major allelic forms, 
class 1 (six haplotypes) and class 2 (35 
haplotypes), which we subdivided into two 
subclasses (c2.1 and c2.2) on the basis of 
multiple sequence alignments (Fig. 6B and 
6D). To quantify the divergence between 
haplotypes, we designated d(c1,c2) as the 
mean number of SNP and indel differences 
between classes c1 and c2. For dblmsp, 
d(c1,c1)=1.77 and d(c2,c2)=22.5, whereas 
d(c1,c2)=185. Similarly for dblmsp2, 
d(c1,c1)=2.9, d(c2.1,c2.1)=34.2, 
d(c2.2,c2.2)=7.0, d(c2.1, c2.2)=61, whereas 
d(c1, c2.1)=239, d(c1,c2.2)=194; 
demonstrating that for both genes, the two 
main allelic classes were deeply diverged. 
To get an estimate of population 
frequencies, we used the alignments to find 
sequence markers characteristic of the main 
classes, and then queried the de Bruijn graph 
for all 434 samples to see which samples 
showed evidence of class 1 and/or class 2 
haplotypes. Using this approach, we were 
able to find evidence for a haplotype from 
either dimorphic form even in samples where 
no call had been made. Our findings 
confirmed that both dimorphic forms co-
existed at high frequencies in each gene and 
all four countries (Fig. 6E). Haplotype 
classes in all 434 samples were clearly 
identified in the region encoding the DBL 
domain, with SNP and indel sites present on 
either side. Outside the DBL domain, a 
strong long-range linkage disequilibrium 
(LD) structure was observed, but all four 
countries showed different patterns. Within 
the DBL domain, however, samples from all 
countries showed both allelic classes at 
appreciable frequencies, a powerful signal of 
balancing selection. Although this had been 
shown previously in Africa, to our 
knowledge this is the first time it has been 
demonstrated in Southeast Asia. In the case 
of dblmsp, one of the two haplotype classes 
was very close to the P. reichenowi sequence 
(Fig. 6C) and is a strong example of 
balancing selection. Until further samples of 
P. reichenowi are sequenced, we will not 
know whether the selection pressure is 
present in P. falciparum only, or whether this 
is a trans-species polymorphism (32). 
Interestingly, the population counts for 
haplotype classes in dblmsp showed much 
higher levels of mixed infection than 
expected (Fig. 6E), from which we inferred 
the existence of a dblmsp paralog, as has 
been suggested before (19). In conclusion, 
the lack of recombination within the class-
defining region of the DBL domain and the 
long-range LD observed on either side of this 
region are striking and provide convincing 
evidence for strong selection pressure on the 
DBL domains of DBLMSP and DBLMSP2, 
suggesting they play an important role in 
parasite biology.  
Most naturally-occurring DBL 
domain variants can bind human IgM - 
Because the genetic variability within dblmsp 
and dblmsp2 is concentrated on the region 
encoding the DBL domain, we tested 
whether the ability to bind IgM was retained 
across DBL sequence variants representing 
the major allelic forms for both genes found 
in our and others’ analyses (18,19). For 
DBLMSP, a total of ten DBL variants from 
three P. falciparum laboratory strains 7G8, 
Dd2, FCR3, six field isolates, and the P. 
reichenowi ortholog sharing between 59 and 
99% sequence identity were selected (Fig. 
S1). Except for the DBL domains from 7G8 
and 028, IgM binding was conserved across 
all variants, including the most divergent 
(384 and P. reichenowi) (Fig. 7A). Similarly 
for DBLMSP2, seven representative DBL 
variants with sequence identities ranging 
from 62 to 98% were selected (Fig. S1). 
Although variant 082 repeatedly did not 
produce protein, all the other six bound 
human IgM (Fig. 7A). Interestingly, while 
the 7G8 and 028 DBLMSP DBL domains 
could not bind human IgM, their shared 
DBLMSP2 DBL sequence was able to do so.  
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To further confirm that binding to 
IgM was conserved amongst sequence 
variants, we performed IgM pull-down from 
long-term parasite culture supernatants from 
the var1 and var13 sub-strains of the IT4 
strain (whose dblmsp sequence is identical to 
that of FCR3) grown in the presence of 
human serum. Following SDS-PAGE and 
incubation with an anti-DBLMSP antibody, a 
band corresponding to the DBLMSP protein 
was identified in the immunoprecipitates 
from parasite cultures but not from the 
negative control supernatant in which no 
parasite was grown (Fig. 7B). In summary, 
despite their high level of sequence 
polymorphism, binding of the DBL domains 
to human IgM was conserved across most of 
the DBLMSP and DBLMSP2 DBL domain 
variants tested. 
Binding of human IgM to their DBL 
domains masks DBLMSP and DBLMSP2 
from host antibodies - The fact that the DBL 
domains of DBLMSP and DBLMSP2 retain 
IgM binding despite their extraordinary 
sequence diversity suggests that DBLMSP 
and DBLMSP2 are targeted by the host 
immune system and that IgM binding 
promotes parasite survival. To determine 
whether individuals regularly exposed to P. 
falciparum mount an immune response to 
DBLMSP and DBLMSP2, we compared the 
immunoreactivity of the full-length proteins 
and DBL domains of both DBLMSP and 
DBLMSP2 from the 3D7 strain to purified 
IgG from Malawian immune adults (33). As 
comparators, we used AMA1 and RH5, 
which have previously been shown to be 
highly and weakly immunoreactive, 
respectively, to antibodies in sera from 
Kenyan, Malian and Senegalese immune 
adults (20,34-36). In the absence of human 
IgM, the immunoreactivity of the full-length 
3D7 isoform of DBLMSP was intermediate, 
being weaker than the immunoreactivity of 
AMA1 but significantly higher than that of 
RH5. Full-length DBLMSP2, however, was 
only very slightly immunoreactive when 
compared to RH5 (Fig. 8A). Consistent with 
the large number of variants observed in P. 
falciparum populations, almost no binding of 
purified hyperimmune IgG was observed to 
either of the two DBL domains. To confirm 
this was not merely because the sera were 
collected from individuals who had not been 
exposed to the 3D7 variants used in this 
assay, we also tested the immunoreactivity of 
other DBL variants for DBLMSP and 
DBLMSP2 and confirmed that they were 
generally not immunoreactive (Fig. 8B). 
Non-immune human IgM is also 
known to bind to some P. falciparum 
PfEMP1 variants expressed at the surface of 
infected erythrocytes, which are associated 
with rosetting or placental malaria (24,37). 
Although the function of IgM binding in 
rosetting remains unclear, association to the 
var2CSA variant responsible for placental 
malaria has been linked to masking of the 
parasite from antigen-specific IgG (38,39). 
To determine whether binding of IgM to the 
DBL domains of DBLMSP and DBLMSP2 
could have a steric immunological “masking” 
effect, we pre-complexed each of the two 
parasite proteins with varying concentrations 
of purified human IgM before incubating 
them with purified hyperimmune IgG. The 
presence of IgM significantly reduced the 
overall immunoreactivity of both full-length 
proteins in a dose-dependent manner, an 
effect that was not observed for AMA1 and 
RH5 (Fig. 8A). Interestingly, the presence of 
IgM had almost no effect on the already very 
limited immunoreactivity of the DBL 
domains. This suggests that binding of IgM 
to DBLMSP and DBLMSP2 masks antibody 
epitopes that are located in other regions of 
the proteins. 
 
DISCUSSION 
The deeply diverged lineages 
preserved in dblmsp and dblmsp2 across P. 
falciparum populations suggests that they are 
under extremely strong selection and must 
have important biological functions. One 
possibility is that they are direct targets of the 
host immune response and are therefore 
potential targets for therapeutic intervention, 
but their function has remained unknown. 
Here, we have demonstrated that the DBL 
domains in both proteins bind directly and 
avidly to host IgM and that this function is 
conserved between the different sequence 
variants identified in P. falciparum isolates. 
The population-based sequence 
analysis of dblmsp and dblmsp2 reported 
here extends earlier findings that both genes 
exhibit a strong allelic dimorphism with 
limited inter-allelic recombination across 
parasite isolates from all populations 
sampled. Strikingly, we have now shown that 
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both allelic classes in dblmsp and dblmsp2 
are present at relatively high frequency in 
populations from West Africa (Ghana, The 
Gambia and Guinea) and Southeast Asia 
(Cambodia), with recombination absent (or 
selected against) within a specific block of 
the DBL domain. The pattern of balancing 
selection preserving two deeply diverged 
haplotypes with reduced recombination has 
previously been seen in msp3, which lacks a 
DBL domain. We would draw a distinction 
between this pattern, and the known 
dimorphism at EBA-175, which is simply a 
single indel, rather than a long preserved 
haplotype. This unusual genetic architecture 
raises the question as to how this dimorphism 
arose and is maintained within the 
population. Following our demonstration that 
the DBL domain can bind host IgM, one 
possibility is that there is a selective 
advantage to binding the two major IgM 
species that either contain or lack a J-chain. 
Dimorphism, however, is also observed in 
genes encoding other merozoite surface 
proteins suggesting selection by a broader 
dichotomous feature within the immune 
system of the host population.  
Despite the large number of 
polymorphisms within the DBL domains of 
both DBLMSP and DBLMSP2, the ability to 
bind the constant region of human IgM was 
broadly conserved across representative 
sequence variants suggesting that this 
interaction plays an important role in the 
parasite biology. Using the known-crystal 
structure of the DBL domain for DBLMSP2 
(9) to model the DBL domains of DBLMSP 
and DBLMSP2 used in our functional 
analysis, we observed that the majority of the 
differences between IgM-binders and -non-
binders are located in helices h1, h2a and h4 
(Fig. S2). These helices could therefore be 
potential binding sites for human IgM. While 
DBLMSP is highly expressed in all mature 
schizonts in the parasitophorous vacuole and 
located on the merozoite surface, DBLMSP2 
is only expressed in a small percentage of 
schizonts (17,40). One suggestion could 
therefore be that DBLMSP2 is expressed at 
the surface of the minority of merozoites 
committed to gametocytogenesis. One 
interesting observation was that while all 
tested DBLMSP2 variants were able to bind 
IgM, some DBLMSP variants did not. While 
this may indicate that dblmsp function - or its 
ability to bind IgM - is dispensable, which 
may be consistent with an earlier finding that 
some dblmsp sequences from field isolates 
contained premature stop codons (18,19), 
three out of fourteen cloned P. falciparum 
lines were found to contain multiple 
sequences for dblmsp (19). These results, 
combined with our observation of a higher 
proportion than expected of mixed 
haplotypes at the dblmsp locus, suggest the 
existence of functional paralogous dblmsp 
genes that can substitute in some isolates and 
strains.  
Our finding that DBLMSP binds to 
IgM with a KD almost four orders of 
magnitude lower than physiological plasma 
IgM concentrations demonstrates that 
DBLMSP would rapidly and irreversibly be 
saturated with host IgM once merozoites are 
exposed to host blood following schizont 
rupture. Consequently, plasma-exposed 
DBLMSP should really be considered as a 
DBLMSP:IgM complex: something that 
must be taken into account when 
investigating the role of these proteins in the 
parasite’s blood stages. Previous research has 
suggested a role for DBLMSP in erythrocyte 
invasion, supported by the presence of a 
DBL domain, which is shared by other 
invasion ligands and its localisation to the 
surface of merozoites (9,40,41), through its 
interaction with MSP1 (42,43). However, 
addition of anti-DBLMSP antibodies at very 
high concentration (20 mg/mL) only had a 
modest 25% decrease on invasion (41), and 
deletion of the dblmsp gene in the 3D7 
laboratory strain did not affect the invasion 
efficiency of the parasite in our study and 
others (41). Presence of human IgM in the 
parasite culture did not either affect the 
ability of wild-type or Δdblmsp parasites to 
invade red blood cells, suggesting that 
DBLMSP is not essentially required for 
parasite invasion in vitro. 
DBL domains, in addition to binding 
erythrocyte receptors from the glycophorin 
family, are known to mediate IgM binding in 
some PfEMP1 variants that are displayed on 
the surface of infected erythrocytes (37,44-
46). This IgM binding, which is involved  in 
adhesion of infected erythrocytes (47,48), has 
recently been suggested to cluster PfEMP1 
on the erythrocyte surface thereby increasing 
their avidity for host receptors (49,50). 
Alternatively, PfEMP1-mediated IgM 
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binding could also be implicated in masking 
from immune IgG, thereby acting as a steric 
shield from the host adaptive immune system 
(38). The conservation of IgM binding to 
DBLMSP, despite high levels of sequence 
polymorphism, suggests it might be an 
important immune evasion strategy for the 
parasite. Consistent with this, a comparative 
immunoreactivity analysis performed with 
purified IgG from Malawian adults revealed 
that the DBL variants of DBLMSP and 
DBLMSP2 are poorly immunogenic, and that 
binding to human IgM further decreases the 
overall immunoreactivity to the full length 
proteins. This masking, however, did not 
seem to affect the accessibility of IgGs to 
other merozoite surface proteins since 
surface labelling of PfMSP1from 3D7 
parasites grown in the presence or absence of 
human IgM looked similar by 
immunofluorescence analysis (data not 
shown). Binding of host IgM to DBLMSP 
and DBLMSP2 might therefore mask 
specific domains that are important for the 
parasite biology on these two proteins but 
whose function remains unknown.  
In conclusion, we have extended the genetic 
characterisation of two P. falciparum genes 
that are under strong balancing selection, and 
shown that the proteins both bind directly 
and with high affinity to host IgM and 
thereby shield the parasite from the host 
adaptive immune response. Given that both 
infected erythrocytes and merozoites are able 
to bind host IgM, IgM-binding proteins could 
be a general immunoprotective mechanism 
used by P. falciparum and possibly other 
parasites and pathogens. 
 
EXPERIMENTAL PROCEDURES 
Ethics statement - Use of 
erythrocytes and serum from human donors 
for P. falciparum culture was approved by 
the NHS Cambridgeshire 4 Research Ethics 
Committee. All subjects provided written 
informed consent. The use of animals to raise 
antisera was performed according to UK 
Home Office governmental regulations and 
in accordance with European directive 
2010/63/EU regarding the use of laboratory 
animals. Research was approved by the 
Sanger Institute Animal Welfare and Ethical 
Review Board (AWERB). 
P. falciparum population sequence 
analysis - 434 samples from Gambian, 
Ghanaian, Guinean, and Cambodian origin, 
sequenced by the MalariaGEN consortium, 
underwent standard QC protocols as 
previously documented (29), and were 
sequenced to a depth of at least 50x with 
Illumina reads (mean read length 74 bp) and 
PCR-based library preparation. Samples 
underwent Cortex assembly using the 
“Independent workflow” as previously 
described (28) using a k-mer of 31. All 
variants called within dblmsp and dblmsp2 
were collated, and clustered into groups 
separated by at least 31 bp, revealing 15 
different haplotypes overlapping the DBL 
domain in dblmsp, and 41 in dblmsp2. Their 
Genbank accession numbers are KM577604 
to KM577618 for dblmsp, and KM589600 to 
KM589640 for dblmsp2. 
Recombinant protein production - 
All Plasmodium falciparum proteins were 
produced recombinantly by transient 
transfection of human embryonic kidney 
(HEK293E) cells (51) essentially as 
described (20) except Py MSP119 (52). 
Briefly, chemically synthesised genes were 
codon-optimised for mammalian expression, 
cloned in frame with an exogenous signal 
peptide (53) and potential N-linked 
glycosylation sequons mutated to prevent 
inappropriate glycosylation of Plasmodium 
proteins. All recombinant proteins contain a 
C-terminal Cd4d3+4 tag (54) followed by 
either an enzymatically biotinylatable 
sequence, a 6-His tag, or a pentamerisation 
sequence followed by β-lactamase (55). 
Monobiotinylated proteins were produced by 
cotransfecting with a plasmid encoding 
secreted BirA (55,56). Proteins were 
processed and purified using His-Trap 
purification columns (GE Healthcare) as 
previously described (57,58). 
Protein purification from human 
serum or parasite culture supernatant - 
Streptavidin-coated paramagnetic beads (100 
µL, 1 µm diameter, Life Technologies) were 
saturated with 20 µg enzymatically 
monobiotinylated DBLMSP or a Cd4 tag-
alone control, isolated with a magnet and 
washed three times with PBS before 
incubating with 1 mL filtered human serum 
(Sigma) for one hour at 4°C. Beads were 
washed four times with 1 mL PBS and eluted 
with 200 μL 1% SDS. 20 μL were resolved 
by SDS-PAGE under reducing conditions, 
stained with SYPRO Orange (Sigma) and the 
 at LIV
ERPO
O
L SCH
O
O
L O
F TRO
PICA
L M
ED
ICIN
E on M
ay 31, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Human IgM Binds Broadly Diverged DBLMSP Protein Variants 
 
9 
 
gel image captured on a Typhoon 9400 
phosphoimager (GE Healthcare). 
Anti-human IgM agarose beads 
(Sigma) were incubated with long-term 
parasite culture supernatants from the IT4 
var1 and var13 strains grown in the presence 
of human serum, or control culture medium 
without parasite for 1 week at 37°C. After 
five washes in PBS, beads were resuspended 
in loading buffer in the presence or absence 
of DTT, and eluates blotted onto 
nitrocellulose membranes (Amersham 
Protran) followed by blocking in PBS/0.1% 
Tween-20 / 5% non-fat milk powder) and 
incubated for 1h with a rabbit anti-full-length 
DBLMSP antibody at a 1:100 dilution. After 
further washes, the membrane was incubated 
with an anti-rabbit HRP-conjugated IgG 
secondary antibody (1:1000, Sigma) and 
developed using 3’,3’-Diaminobenzidine 
(DAB; DAKO) according to manufacturer’s 
instructions. 
Parasite culture and transfection - 
Plasmodium falciparum parasites (3D7 
strain) were grown in vitro in RPMI 1640 
medium containing Albumax II or 10% 
human serum as described previously (59), 
and transfected using standard protocols (60). 
Transfected parasite cultures were selected 
with 10 nM WR99210 (kind gift of Jacobus 
Pharmaceuticals) and 10 µM ganciclovir 
(Sigma Aldrich) and cloned by limiting 
dilution. 
dblmsp knockout construct design 
and characterisation - For gene disruption 
via double homologous recombination in P. 
falciparum, a 520-bp 5’ fragment (F1 region) 
and a 659-bp 3’ fragment (F2 region) 
comprising ORF and UTR sequences of 
dblmsp were amplified using primers 
348F1for (5’- 
AATAAACCGCGGCACATTTAATTAAG
GTTGTATTTACTG-3’, SacII site 
underlined), 348F1rev (5’- 
TTATTTAGATCTGACATTTTTAATACC
CTTACAAAAATTTTC-3’; BglII site 
underlined), 348F2for (5’- 
TTATTTATCGATAGTGTTAGGGATTCT
AGTAATCTAGATCAACG-3’; ClaI site 
underlined) and 348F2rev (5’- 
TTTATTCCTAGGCATATCTTCTGTCAA
ACCCTTAAAAATAGTTTC -3’; AvrII site 
underlined). Amplification products were 
digested using SacII + BglII (F1 flank) and 
ClaI + AvrII (F2 flank) and cloned into 
pHTK vector (60), resulting in construct 
pHTKDBLMSP. 
For Southern blotting, the genomic DNA 
from P. falciparum 3D7 wild-type parasites, 
transgenic parasites in presence of WR99210 
with or without ganciclovir, and clonal 
transfectants were digested with EcoRV and 
BglII, separated on a 0.7% agarose gel and 
transferred onto a nitrocellulose membrane 
using standard techniques. A radioactive 
probe was generated from the 520-bp F1 
flank in construct pHTKDBLMSP using 
random priming (Decaprime II, Ambion). 
Hybridisation was carried out at 62°C 
overnight before stringent washes and 
autoradiography. 
For Western blot analysis, total lysate from 1 
x 106 schizonts was prepared in SDS 
reducing sample buffer and boiled at 95°C 
for 5 min. The lysates were separated on pre-
cast 10 % Bis Tris NuPAGE polyacrylamide 
gels (Invitrogen) and transferred to 
nitrocellulose membranes by electroblotting. 
Membranes were blocked, and incubated 
with rabbit anti-DBLMSPSPAM (1:2000), 
rabbit anti-MSP3 (1:2000), mouse anti-MSP2 
(1:1000; (61)) and rat anti-BiP antibodies 
(1:1000). Bound antibodies were detected 
with horseradish peroxidase-conjugated 
secondary antibodies (Biorad). 
For immunofluorescence analysis, thin 
smears of schizont and merozoites from 
wild-type and ΔDBLMSP parasites were 
incubated with anti-DBLMSPSPAM 
(1:2000) and anti-MSP119 (clone 1E1, 
1:3000) antibodies diluted in 3% BSA/PBS, 
and incubated for one hour at room 
temperature before washes and incubation 
with secondary AlexaFluor-labelled (488 and 
594; Invitrogen) antibodies at 1:5000. 
Human IgM binding to merozoites - 
To detect IgM binding to merozoites, 
parasites were tightly synchronised before 
late stage schizonts were purified using 70% 
Percoll, put back into culture containing 
RPMI + Albumax II with the addition of 
20% human serum, or 0.125 mg/mL purified 
human IgM (Sigma). IgM was detected using 
an AlexaFluor 488 goat anti-human IgM μ 
chain antibody (Molecular Probes; pre-
adsorbed against human IgG) at 1:1000. 
Slides were viewed on a Zeiss Axioplan 2 
imaging system with Plan Apochromat 
100x/1.4 oil immersion objective. Images 
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were captured using Axiovision 4.6.3 
software and edited using Adobe Photoshop. 
For immunogold-labelling, merozoites were 
fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffer (PB) at pH 7.4 for 1 hour at 
room temperature, rinsed 3 times in buffer, 
infiltrated with 1% and then 10% gelatin 
before immersing in 2.3 M sucrose in PB 
overnight at 4°C for cryoprotection. Frozen 
samples were prepared by mounting onto 
aluminium pins and rapidly immersing in 
liquid nitrogen in preparation for ultrathin 80 
nm sectioning on a Leica EM FC6 
ultramicrotome. Ultra-thin sections were 
labelled as per Tokuyasu (62), with a rabbit 
anti-human IgM antiserum (abcam) diluted 
1:25, and detected with 10 nm protein A 
gold. Imaging was performed on an FEI 
120kV Spirit Biotwin with a Tietz F4.15 
CCD camera. 
Cell culture of transfectomas 
secreting anti-DNP human IgM - 
Transfectomas expressing anti-DNP IgM 
antibodies containing the human constant 
heavy chains either with (Xp) or without 
(Gp) the mouse J-chain (22) were a kind gift 
of Professor Marc Shulman. Transfectomas 
were grown in DMEM supplemented with 
10% foetal bovine serum, 0.6 mg/mL G418, 
and 0.02% β-mercaptoethanol, and 
supernatants harvested and filtered before use 
in ELISA and AVEXIS experiments. 
Enzyme-linked immunosorbent assay 
(ELISA) and primary antibodies - 
Biotinylated recombinant P. falciparum 
proteins were normalised and immobilised on 
streptavidin-coated plates, preblocked with 
HBS-0.1%Tween-20 (HBST)/2% BSA for 
30 mins. After washing with HBST, serial 
dilutions of either pooled human sera from 
ten malaria-exposed or malaria-naïve 
individuals, transfectoma cell culture 
supernatants, or purified primary antibodies 
were incubated for 90 minutes. Plates were 
again washed with HBST, and appropriate 
alkaline-phosphatase-conjugated secondary 
antibodies incubated for 1 h. Plates were 
washed with HBST, and once with HBS 
before adding p-nitrophenyl at 1 mg/mL, and 
absorbance at 405 nm quantified on either a 
PHERAstar Plus or FLUOstar Optima plate 
reader (BMG Labtech). For domain-mapping 
experiments involving chimaeric human 
antibodies, an HRP-conjugated anti-human 
secondary antibody was used. Following 
PBS washes, tetramethylbenzidine substrate 
was added, and absorbance quantified at 
450nm. All procedures were performed at 
room temperature. Primary antibodies used 
were: anti-Cd4 OX68 (1:1000; AbD 
Serotec); purified human IgA, IgE, IgM (3 
μg/mL; Sigma), or IgG (3 μg/mL; Bethyl 
laboratories); human, goat, rabbit, guinea pig 
or bovine serum (1:1000; Sigma); purified 
mouse IgM (10 μg/mL MEM-150; Abcam); 
or domain-swapped human antibodies at 25 
nM (25,26). All alkaline-phosphatase-
conjugated secondary antibodies were from 
Sigma, except anti-rabbit immunoglobulins 
(Jackson Immunoresearch). 
Mapping DBLMSP and DBLMSP2 
binding site on human IgM - Domain-
specific monoclonal antibodies that bind the 
human constant μ chain (23) were incubated 
for 90 mins with either biotinylated human 
IgM or biotinylated human IgG (used as a 
control) before washing and adding 
pentamerised, β-lactamase-tagged DBLMSP 
or DBLMSP2 and incubating for a further 
hour. After washes, the β-lactamase substrate 
nitrocefin was added at 125 μg/mL and 
colorimetric turnover measured by 
absorbance reading at 485 nm. Antibodies 
were biotinylated using EZ-link Sulfo-NHS-
LC-biotin (Pierce). 
Construction of the homology model for the 
DBL domain of DBLMSP and DBLMSP2 
was done using the Phyre2 engine. 
Surface plasmon resonance analysis 
- Surface plasmon resonance analysis was 
performed on a BIAcore T100 instrument at 
37°C in HBS-EP buffer, using streptavidin-
coated sensor chips (GE Healthcare) 
essentially as described (63). Briefly, 300 
response units (RU) of the biotinylated Cd4 
tag was used as a reference and molar 
equivalents of full-length biotinylated 
DBLMSP or DBLMSP2 were immobilised in 
query flow cells. Increasing concentrations of 
purified human IgM were injected for 30min 
at 10 μL/min until equilibrium had been 
reached and binding was quantified from 
reference-subtracted sensorgrams. The 
surface was regenerated after each cycle with 
either 2 M NaCl for 60 seconds for 
DBLMSP, or 10 mM glycine:HCl pH3.0 for 
20 seconds for DBLMSP2 and duplicate 
injections of the same concentration of IgM 
in each experiment showed no loss of activity 
between each cycle. For the binding analysis 
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using the DBL domains only, 500 RU of 
biotinylated human IgG were immobilised as 
a reference and a molar equivalent of 
biotinylated human IgM was immobilised in 
the query flow cell. Each purified DBL 
domain was resolved by gel filtration on a 
Superdex 200 Tricorn 10/600 column to 
remove any protein aggregates that might 
interfere with the kinetic measurements. 
Increasing concentrations of DBL domains 
were injected at 20 μL/min for 2 minutes in 
each cycle until equilibrium had been 
reached. The surface was regenerated after 
each cycle with 2 M NaCl for 60 seconds, 
with no loss of activity. Data analysis was 
performed using BIAcore analysis software. 
Generation of polyclonal antibodies 
- A polyclonal antibody against the SPAM 
fragment of DBLMSP was generated. 
Briefly, a 619 bp DNA product 
(corresponding to amino acids 439 – 633 of 
DBLMSP) was amplified from 3D7 genomic 
DNA using primers 348ForPET30 (5’-
GGTATTGAGGGTCGCAAAGAATTTAA
AGATAACGTTACACTTCTTAAAGC-3’) 
and 
 348revbPET30 (5’-
AGAGGAGAGTTAGAGCCTTAACTTTG
TTGTTGATTACTGAGTTCTTTTTCC-3’) 
and cloned into pET-30 Xa/LIC expression 
vector (Novagen). Expression plasmids were 
sequenced before transformation into E.coli 
BL21(DE3)pLysS and expression was 
induced with 1 mM IPTG for 4 h at 30°C. 
Recombinant DBLMSPSPAM protein was 
purified using Ni-NTA affinity 
chromatography under non-denaturing 
conditions. Purified rDBLMSPSPAM was 
used for antibody production in rabbits 
(Harlan Laboratories Inc.) following standard 
procedures. Rabbit antibodies were 
subsequently affinity purified using 
rDBLMSPSPAM coupled to CNBr-activated 
Sepharose 4B (GE Healthcare) and IgG-
selected using protein G-Sepharose (Sigma 
Aldrich). 
Polyclonal antibodies against the full-length 
3D7 form of DBLMSP were raised in rabbits 
(Cambridge Research Biochemicals). The 
full-length, His-tagged protein was produced 
in mammalian cells, purified by Ni-NTA 
chromatography using HisTrap column (GE 
Healthcare), and injected every two weeks 
over an 11-weeks period with the first 
injection in complete Freund’s adjuvant, and 
the subsequent five injections in incomplete 
adjuvant. Rabbit antibodies were 
subsequently affinity purified using HiTrap 
protein G columns (GE Healthcare).  
Immunoreactivity analysis - 
Pentamerised, normalised β-lactamase-
tagged parasite proteins were incubated with 
serial dilutions of purified human IgM for 90 
minutes before being transferred to 20 μg/mL 
purified IgG from Malawian adults (33), 
immobilised on ProteinG-coated microtitre 
plates (Pierce). After 60 minutes, the plates 
were washed and incubated with nitrocefin at 
125 μg/mL. The incubations were performed 
at room temperature and absorbance read at 
485nm as described above. 
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FIGURE LEGENDS 
 
FIGURE 1. Recombinant P. falciparum DBLMSP and DBLMSP2 bind human IgM. A. Anti-biotin 
Western-blot showing expression of recombinant monobiotinylated DBLMSP and DBLMSP2 
proteins from mammalian cells. B. DBLMSP and DBLMSP2 are immunoreactive with control, naïve 
human sera. Enzymatically monobiotinylated recombinant parasite proteins were immobilised on 
streptavidin-coated plates and their immunoreactivity to pooled sera from either unexposed 
individuals (black bars) or immune Kenyan adults (grey bars) was tested. C. DBLMSP (blue) and 
DBLMSP2 (red) bind purified human IgM and no other immunoglobulin isotype, relative to no 
immunoglobulin control (ctl).  D. DBLMSP and DBLMSP2 binding was restricted to human IgM, 
and did not bind sera from other species, including purified murine IgM.  E. Streptavidin-coated 
paramagnetic beads were coated in monobiotinylated 6His-tagged recombinant DBLMSP or a control 
protein (Cd4-d3+4) and incubated in the presence of normal human serum. Following elution and 
resolution by SDS-PAGE, 80- and 25-kDa bands corresponding to the heavy (H) and light (L) chains 
of human IgM, respectively, were observed in the DBLMSP but not the negative control pull-down. 
Purified albumin, DBLMSP and IgM protein are shown for comparison on the left. F. Both DBLMSP 
and DBLMSP2 bound chimaeric IgM containing human heavy chains regardless of whether it was 
antigen-bound (right panel), or not (left panel). Both DBLMSP and DBLMSP2 could bind IgM that 
contained or lacked a J-chain, although DBLMSP2 binding to IgM lacking a J-chain was reproducibly 
weaker. Negative control (ctl) was the Cd4 tag alone. B , C, D and F represent one representative 
from two or more ELISA experiments; bars represent means ± SD; n = 3 replicate wells.  
 
FIGURE 2. The DBL domains directly interact with the Cμ4 domain of human IgM. A. Monoclonal 
antibodies to human IgM with known domain-specific epitopes were used to map the DBLMSP and 
DBLMSP2 binding domain on human IgM heavy chain. Binding of both parasite proteins was 
inhibited by the Cμ4-specific 1G6 antibody, but not by antibodies recognising other domains or by the 
IF11 antibody, which is known to bind a different epitope on Cμ4. Negative control (ctl) was 
immobilised biotinylated IgG. B. DBLMSP and DBLMSP2 bound the Cµ4 domain of human IgM. 
Systematic testing of a small panel of chimaeric human immunoglobulins containing different 
combinations of heavy chain domains from either IgA, IgG and IgM (numbered and labelled α, γ, µ, 
respectively) showed DBLMSP and DBLMSP2 bound the Cµ4 domain only. C. The DBL domain of 
DBLMSP and DBLMSP2 bound human IgM. Fragments encompassing the DBL, but not the SPAM 
domain, of both DBLMSP and DBLMSP2 bound human IgM indistinguishably from the full-length 
(FL) protein. Bars represent mean ± SD in all panels; n = 3 (A, C) or 4 (B) replicate wells.  
 
FIGURE 3. DBLMSP and DBLMSP2 form oligomers and their DBL domain bind to human IgM 
with high affinity. A. Size exclusion chromatography showing polydisperse profile of full-length 
DBLMSP (left panel, blue) and DBLMSP2 (right panel, red). The indicated fractions were resolved 
by denaturing SDS-PAGE gel and the insets show that each peak is largely composed of the full-
length protein. B. The SPAM fragment of DBLMSP2 induces oligomerisation. Size exclusion 
chromatography showed purified SPAM-Cd4 (green) was polydisperse, containing oligomers of 
higher molecular mass relative to DBL-Cd4 (orange) and the Cd4 tag alone (black). The predicted 
monomeric molecular mass of SPAM-Cd4 is 52kDa: the major peak lies within the void volume of 
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the column used, while the other two peaks correspond to theoretical molecular masses of ~480 and 
~200kDa, respectively.  Molecular markers shown in blue are: thyroglobulin (669), ferritin (440), 
aldolase (158), conalbumin (75) and carbonic anhydrase (29 kDa) C. DBLMSP and DBLMSP2 bind 
directly and avidly to human IgM. Equilibrium binding analysis of full-length DBLMSP (blue) and 
DBLMSP2 (red) to human IgM, as determined by surface plasmon resonance. Biotinylated DBLMSP 
or DBLMSP2 were immobilised on a streptavidin-coated chip and two-fold serial dilutions of human 
IgM were used as analyte until equilibrium was reached. Reference-subtracted data were plotted and 
the KDs estimated by fitting to a simple Langmuir binding isotherm. D. Surface plasmon resonance 
was used to quantify the biophysical parameters of the monomeric DBL domains of DBLMSP and 
DBLMSP2 binding to human IgM. Increasing concentrations of purified DBL domains for both 
DBLMSP (blue, left panel), or DBLMSP2 (red, right panel) were injected as analytes over 
immobilised human IgM on a sensor chip until equilibrium had been reached (see inset). Reference-
subtracted binding data were plotted as a function of injected DBL protein concentration, and the KDs 
estimated by fitting to a simple (1:1 binding) Langmuir binding isotherm. Binding of both DBL 
domains showed clear evidence of saturation demonstrating the specificity of the interaction. The 
DBL domain of DBLMSP reproducibly bound with approximately 10-fold higher affinity than 
DBLMSP2.  
 
FIGURE 4. Generation of dblmsp knockout parasites. A. Schematic representation of knockout 
strategy for dblmsp. B. Southern Blot on EcoRV /BglII-digested genomic DNA from wild-type and 
transgenic parasites: genomic DNA was extracted from P. falciparum 3D7 wild-type parasites, 
transgenic parasites in presence of WR99210 with or without ganciclovir, and clonal transfectants as 
indicated on the top of the blot. Bands corresponding to the endogenous gene, episome and disrupted 
gene locus are indicated with arrows. Size markers are given on the left of the panel (in kb). C. 
Western blot analysis from the lysate of 1 x 106 schizonts prepared in SDS reducing sample buffer 
and incubated with the corresponding primary antibodies. DBLMSP could readily be detected in the 
lysate of wild-type parasites, but not of clones A and B. Sizes of molecular mass markers (kDa) are 
shown on the left of the panels. D. Indirect immunofluorescence assay on thin smears of schizont and 
merozoites from wild-type and Δdblmsp parasites showing expression of DBLMSP (green; first 
panel) and MSP1 (red; second panel). Third panel depicts the overlay of both antibodies with the 
nuclear stain DAPI; forth panel shows the corresponding brightfield images. Size bars represent 1μm. 
 
FIGURE 5. Human IgM bind native DBLMSP protein. A. Indirect immunofluorescence assay for 
detection of human IgM was conducted on live wild-type and Δdblmsp merozoites grown in either 
20% human serum (+HS) or 0.125 mg/ml purified human IgM (+IgM). AlexaFluor 488 goat anti-
human IgM μ chain antibodies are depicted in green (panel 1). Panel 2 corresponds to the bright field 
image, and panel 3 shows the overlay. B. Immunoelectron microscopy showing the presence of 
human IgM at the surface of wild-type, but not Δdblmsp purified merozoites. Size bar represents 200 
nm. C. Addition of 1 mg/mL purified human IgM to both wild-type and Δdblmsp parasites grown in 
Albumax did not affect their ability to infect red blood cells. Bars represent mean ± SD; n = 3 
replicate wells. A representative of four independent experiments is presented. 
 
FIGURE 6. Genome sequencing of 434 P. falciparum isolates reveals dblmsp and dblmsp2 are 
dimorphic and divergent. A. The number of segregating sites across chromosome 10 from 434 P. 
falciparum isolates sequenced from The Gambia, Ghana, Guinea, and Cambodia, plotted in half-
overlapping 500bp windows showing isolated regions of high sequence diversity. B. Cluster 
dendrogram of the 15 dblmsp haplotypes (left) and 41 dblmsp2 haplotypes (right) identified in the 
study. Both trees were obtained using ClustalW. C. A schematic representation of the amino acid 
multiple sequence alignment of six representative exemplar haplotypes for the DBL domain of 
DBLMSP between residues C144 and R344, and the P. reichenowi (Pr) ortholog. Note the long non-
recombining region has two alternate allelic forms (orange and yellow), of which the yellow is 
relatively close to the P. reichenowi sequence (shown in brown). A phylogenetic tree indicating the 
relationships of the sequences built by clustering haplotypes based on a distance matrix (where 
distance corresponds to the number of SNP and indel differences) is shown on the left. D. A 
schematic representation of the amino-acid multiple sequence alignment of ten representative 
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exemplar haplotypes for the DBL domain of DBLMSP2 between residues E102 and G550. Note the 
long non-recombining region has two alternate allelic forms (orange for class 1 and purple/dark green 
for subclasses 2.1/2.2, respectively). A phylogenetic tree indicating the relationships of the sequences 
built by clustering haplotypes based on a distance matrix (where distance corresponds to the number 
of SNP and indel differences) is shown on the left. E. Haplotype structure in the region of DBLMSP; 
rows are samples and columns are polymorphic sites. Outside the DBL domain, the reference allele is 
shown in red, alternate allele in blue, and missing data in white. Within the DBL domain, the class of 
allele found in each sample is shown: class1 only (yellow), class 2 only (green) or both present 
(black). Samples are split by country and then sorted first by DBLMSP type, and then by haplotype 
structure outside the DBL domain. Note that the x-axis is not drawn to scale. 
 
FIGURE 7. Binding to human IgM is conserved across DBLMSP and DBLMSP2 variants. A. IgM 
binding to representative DBL domains from eleven DBLMSP (blue) and seven DBLMSP2 (red) was 
conserved. Only the DBLMSP DBL domains from the laboratory strain 7G8 and isolate 028 did not 
show binding. A representative from two experiments is shown in each panel. Bars represent mean ± 
SD; n = 3 replicate wells. B. Western-blot showing that DBLMSP is associated to human IgM that 
were purified from long term cultures of IT4 var1 or var13 parasite; the negative control corresponds 
to culture medium without parasites. Note that the anti-rabbit secondary antibody used in this 
experiment cross-reacts with the light (25kDa) and heavy chains (50kDa) of human IgG. 
 
FIGURE 8. IgM binding to full-length DBLMSP and DBLMSP2 masks them from the host immune 
system. A. Normalised amounts of full-length (FL) DBLMSP, DBLMSP2, RH5, the entire 
ectodomains of AMA1, or the DBL domain of both DBLMSP and DBLMSP2 expressed as β-
lactamase-tagged pentamers were pre-complexed with varying concentrations of human IgM, and the 
immunoreactivity of the complexes to purified IgG from Malawian adults quantified by β-lactamase 
substrate hydrolysis. The immunoreactivity of full-length DBLMSP and DBLMSP2 decreased with 
increasing concentrations of IgM. The AMA1 and RH5 proteins were used as exemplars of high and 
low immunoreactivity, respectively, and their immunoreactivity, as well as those of the DBL domains, 
was only marginally affected by the presence of IgM. * 0.02<p≤0.05; ** 0.01<p≤0.02; *** p<0.01; 
two-tailed paired t-test. Shown is one representative of three experiments. Bars represent mean ± SD; 
n = 3 replicate wells; all proteins were the 3D7 strain sequences. B. DBL domains from a 
representative panel of DBLMSP and DBLMSP2 variants were expressed as β-lactamase pentamers 
and pre-complexed with varying concentrations of human IgM before incubating with purified 
immobilised IgG from Malawian adults. The immunoreactivity of all the DBL domains was very low, 
irrespective of the IgM concentration. The entire ectodomains of AMA1 and RH5 from the 3D7 strain 
were used as exemplars of high and low immunoreactivity, respectively. Bars represent mean ± SD; n 
= 3 replicate wells. 
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A 
DBLMSP DBL variants DNA Protein Boundaries 
3D7  XM_001347596 XP_001347632 S135-D435 
7G8  FJ406853 ACR09793 S103-D405 
Dd2 FJ406861 ACR09800 S103-D403 
FCR3  FJ406860 ACR09799 S103-D403 
P. reichenowi  FJ406845 ACR09785 S103-D403 
Isolate 002 FJ556030 ACR49847 S103-D403 
Isolate 017  FJ556042 ACR49858 S103-D403 
Isolate 026  FJ556049 ACR49864 S103-D405 
Isolate 067  FJ556070 ACR49882 S103-D403 
Isolate 028  HM000310 ADJ58681 S103-D405 
Isolate 384 HM000317 ADJ58688 S103-D405 
    
DBLMSP2 DBL variants DNA Protein Boundaries 
3D7  XM_001347603 XP_001347639 T154-V454 
Isolate 020 HM000330 ADI99310 H134-V436 
Isolate 023 HM000332 ADI99312 S131-V430 
Isolate 028 HM000334 ADI99314 T131-V431 
Isolate 082  HM000336 ADI99316 S131-V431 
Isolate 093  HM000339 ADI99319 T131-V430 
Isolate 097  HM000340 ADI99320 T131-V430 
Isolate 384 HM000390 ADI99370 S131-V431 
 
B 
 
C 
 
 
Figure S1. Details of the DBLMSP and DBLMSP2 DBL domains used for functional analysis 
A. DNA and protein accession numbers of the different DBL domains used in this study. The amino-
acid boundaries of each DBL domain are indicated in the right-hand column. B. Sequence alignment 
of the DBLMSP DBL domains. A common feature of the two DBL domains that do not bind IgM 
(7G8 and isolate 028) is the presence of a Glu amino-acid residue at position 310, where all other 
domains contain either a His or an Ala residue. To test whether we could narrow the binding site to 
IgM even further, we used site-directed mutagenesis and substituted the Glu and Leu present at 
positions 310-311 in the non-binding domain of isolate 028 for Ala and Gln residues present in the 
binding domain of isolate 384 (red box). These substitutions were however not sufficient to restore 
binding of the DBL domain of isolate 028 to human IgM, suggesting that these two residues are not 
sufficient to confer the IgM-binding property. C. Sequence alignment of the DBLMSP2 DBL 
domains. Sequence alignments of the different DBL variants were performed with ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) and displayed using Boxshade (http://embnet.vital-
it.ch/software/BOX_form.html).  
 
  
 
Figure S2. Modelled structural comparisons between IgM-binding and –non-binding DBL 
domains 
The structures of the IgM-binding DBL domains from DBLMSP and DBLMSP2 were modelled using the 
Phyre2 software and the known crystal structure of the DBL domain from DBLMSP2. The IgM-binding DBL 
domain models are shown in beige, and the regions that differ in the non-binding DBL domains (isolate 028 and 
strain 7G8 in DBLMSP), are superimposed and highlighted in red (left panel). The right panel shows a 180° 
rotation of the same structure. Most differences were observed in helices h1, h2a, h4 and h7. Polymorphisms in 
h7 are, however, also frequently observed around the same positions amongst DBL domains that have retained 
their IgM-binding ability. The IgM-binding site is therefore most likely to be in helices h1, h2a or h4. 
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